Skip to main content
OpenTrials

Clinical trial condition

Endocrine System Diseases

Explore clinical trials studying Endocrine System Diseases. Study availability and eligibility vary by location and protocol.

26,369 public trials 3,582 recruiting studies
Refine in advanced search Browse all conditions

Endocrine System Diseases trial results

Active, Not Recruiting

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot

NCT04564443

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +11 more
Locations
  • CCR Research San Francisco, California, United States
  • Doctors Research Network South Miami, Florida, United States
  • Foot and Ankle Associates of the Mid-Atlantic Frederick, Maryland, United States
  • Foot and Ankle Associates of the Mid-Atlantic Raleigh, North Carolina, United States
View Trial Details
Active, Not Recruiting

Nordic Pancreatic Cancer Trial (NorPACT) - 1

NCT02919787

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Odense University Hospital Odense, Denmark
  • Helsinki University Hospital Helsinki, Finland
  • Oslo University Hospital Oslo, Norway
  • Haukeland University Hospital Bergen, Norway
View all 13 locations
View Trial Details
Active, Not Recruiting

Cardiac Arrhythmia in Patients with End-Stage Renal Disease

NCT04841304

Conditions
Arrhythmias, Cardiac, Cardiac Arrhythmia, Cardiovascular Diseases, +10 more
Locations
  • Department of Nephrology, Rigshospitalet Copenhagen, Denmark
  • Department of Nephrology, Herlev Hospital Herlev, Denmark
  • Department of Nephrology, North Zealand Hospital Hillerød, Denmark
  • Department of Nephrology, Holbæk Sygehus Holbæk, Denmark
View Trial Details
Active, Not Recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory University Atlanta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • R.J.Zuckerberg Cancer Center Lake Success, New York, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer

NCT06532344

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
  • Seirei Hamamatsu General Hospital Hamamatsu, Shizuoka, Japan
  • Juntendo University Hospital Bunkyō-Ku, Tokyo, Japan
View Trial Details

Related conditions